TAMPA, FL / ACCESSWIRE / October 24, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for third quarter 2022, after market close on November 7, 2022. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.

In addition, management will host a conference call on Monday, November 7, 2022, at 5:00 p.m. Eastern time to discuss TRxADE HEALTH's third quarter 2022 financial results. The call will conclude with a Q&A from participants. To participate, please use the following information:

Q3 2022 Conference Call and Webcast
Date: Monday, November 7, 2022
Time: 5:00 p.m. Eastern time
U.S. Dial-in: 1-844-825-9789
International Dial-in: 1-412-317-5180
Conference ID: 10172776
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1579639&tp_key=b6cea3c0c8

Please dial in at least 10 minutes before the start of the call to ensure timely participation.

A playback of the call will be available through December 7, 2022. To listen, call 1-844-512-2921 within the United States or 1-412-317-6671 when calling internationally and enter replay pin number 10172776. A webcast will also be available for 30 days on the IR section of the Trxade Group website or by clicking the webcast link above.

About TRxADE HEALTH, INC.

TRxADE HEALTH (NASDAQ:MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The Company operates the TRxADE drug procurement marketplace serving approximately 14,000+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth services. For more information on TRxADE HEALTH, please visit the Company's IR website at investors.trxadegroup.com.

Investor Relations:
IR@trxade.com
Investors.trxadegroup.com

SOURCE: TRxADE HEALTH, Inc.